News
Cash runway extended into 2028; expected to enable multiple meaningful clinical data read-outs -- APOE program added to ...
University of Virginia School of Medicine scientists are tapping the power of AI to enhance and accelerate treatment for ...
Researchers, led by Dr Rafael T. M. de Rosales and Dr Graeme Stasiuk, have been awarded £10 million in funding from the ...
This early prototype was just 10 cm wide, but Lawrence’s innovation was so impactful that it earned him the 1939 Nobel Prize ...
At June 30, 2025, the Company's cash and cash equivalents were $695.6 million, after payment of $276.4 million for the Evergreen Theragnostics, Inc. (“Evergreen”) acquisition, which closed early in ...
13h
Fashion Glamp on MSNDopamine: The Brain's Master of AdaptationDopamine is a neurotransmitter often associated with pleasure and reward. It has indeed been found to play an important role in adapting us to new situations. A recent study explains how that works, ...
10h
Verywell Health on MSNUnderstanding Dementia and Alzheimer's: What's the Difference?Alzheimer's disease is the most common type of dementia. All types of dementia involve a gradual loss of functions such as ...
This NDA acceptance builds on the success of Lantheus’ market-leading PSMA PET imaging agent, PYLARIFY, which has demonstrated high diagnostic performance and meaningful impact on clinical decision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results